Citation Title DOI Mention to respiratory disease except from asthma Number (%) respiratory disease except from asthma Mention of asthma Number (%) asthma patients Number COVID-19 patients
Aretz M, et al. 2020 Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State 10.1001/jama.2020.4326 Yes COPD: 7 (33.3%) Yes 2 (9.1%) 21
Bhatraju PK, et al. 2020 Covid-19 in Critically Ill Patients in the Seattle Region — Case Series 10.1056/NEJMoa2004500 Yes COPD: 1 (4%) Yes 3 (12.5%) 24
Chao JY, et al. 2020 Clinical Characteristics and Outcomes of Hospitalized and Critically Ill Children and Adolescents with Coronavirus Disease 2019 (COVID-19) at a Tertiary Care Medical Center in New York City 10.1016/j.jpeds.2020.05.006 No - Yes 11 (24.4%) 46
Duanmu Y, et al. 2020 Characteristics of Emergency Department Patients With COVID-19 at a Single Site in Northern California: Clinical Observations and Public Health Implications 10.1111/acem.14003 Yes COPD: 1 (10%) Yes 10 (10%) 100
Fan J, et al. 2020 The epidemiology of reverse transmission of COVID-19 in Gansu Province, China. 10.1016/j.tmaid.2020.101741 Yes COPD: N/A Yes N/A 37
Ferguson J, et al. 2020 Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge Conditions, Northern California, USA, March-April 2020 10.3201/eid2608.201776 Yes COPD: 10 (13.9%) same patients with asthma Yes 10 (13.9%) 72
Fernandéz R, et al. 2020 COVID-19 in Solid Organ Transplant Recipients: A Single-Center Case Series From Spain 10.1111/ajt.15929 No - Yes 1 (5.55%) 18
Gold JAW, et al. 2020 Characteristics and Clinical Outcomes of Adult Patients Hospitalized With COVID-19 - Georgia, March 2020 10.15585/mmwr.mm6918e1 Yes COPD: 16 (5.2%) Yes 32 (10.5%) 305
Lechien JR, et al. 2020 Clinical and Epidemiological Characteristics of 1,420 European Patients With Mild-To-Moderate Coronavirus Disease 2019 10.1111/joim.13089 Yes Respiratory insufficiency 10 (0.7%) Yes 93 (6.5%) 1420
Li X, et al. 2020 Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan 10.1016/j.jaci.2020.04.006 Yes COPD: 17 (3.1%) Yes 5 (0.9%) 548
Merza MA, et al. 2020 COVID-19 outbreak in Iraqi Kurdistan: The first report characterizing epidemiological, clinical, laboratory, and radiological findings of the disease. 10.1016/j.dsx.2020.04.047 Yes Bronchitis: 2 (13.3%) same patients with asthma Yes 2 (13.3%) 15
Richardson S, et al. 2020 Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. 10.1001/jama.2020.6775 Yes COPD: 287 (5.4%) Yes 479 (9%) 5700
Sultan I, et al. 2020 The Role of Extracorporeal Life Support for Patients With COVID-19: Preliminary Results From a Statewide Experience 10.1111/jocs.14583 No - Yes N/A 10
Wang X, et al. 2020 Nosocomial Outbreak of 2019 Novel Coronavirus Pneumonia in Wuhan, China 10.1183/13993003.00544-2020 No - Yes 2 (5.7%) 35
Yao Q, et al. 2020 Retrospective Study of Risk Factors for Severe SARS-Cov-2 Infections in Hospitalized Adult Patients 10.20452/pamw.15312 Yes Pulmonary disease (bronchiectasis, COPD or asthma): 3 (2.8%) Yes 3 (2.8%) same patients with other pulmonary diseases 108
Zhang JJ, et al. 2020 Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China 10.1111/all.14238 Yes COPD: 2 (1.4%) Yes 0 140
Zhang L, et al. 2020 Clinical Characteristics of COVID-19-infected Cancer Patients: A Retrospective Case Study in Three Hospitals Within Wuhan, China 10.1016/j.annonc.2020.03.296 Yes COPD: 1 (3.5%) same patient with asthma Yes 1 (3.5%) 28
Zhou X, et al. 2020 Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) Patients With Hypertension on Renin-Angiotensin System Inhibitors 10.1080/10641963.2020.1764018 Yes COPD:3 (2.7%) Yes 1 (0.9%) 110